CLINICAL-TRIALS WITH THE HEXITOL DERIVATIVES IN THE UNITED-STATES

被引：0

作者：

CHIUTEN, DF

ROZENCWEIG, M

VONHOFF, DD

MUGGIA, FM

机构：

[1] NCI,PROGRAM CLIN ONCOL,BETHESDA,MD 20205

[2] NCI,PEDIAT ONCOL BRANCH,BETHESDA,MD 20205

来源：

关键词：

D O I：

10.1002/1097-0142(19810201)47:3<442::AID-CNCR2820470304>3.0.CO;2-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：442 / 451

页数：10

共 70 条

[1] AFRA D, 1978, EXCERPTA MEDICA 433, P95
[2] AHMANN DL, 1976, CANCER TREAT REP, V60, P1681
[3] AHMANN DL, 1977, CANCER TREAT REP, V61, P81
[4] ANDREWS NC, 1971, CANCER CHEMOTH REP 1, V55, P61
[5] ANDREWS NC, 1974, CANCER CHEMOTH REP 1, V58, P653
[6] CELL KILLING, KINETICS, AND RECOVERY RESPONSES INDUCED BY 1,2-5,6-DIANHYDROGALACTITOL IN DIVIDING AND NONDIVIDING CELLS INVITRO
BARRANCO, SC
FLOURNOY, DR
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (03) : 657 - 663
[7] BELEJ MA, 1972, CLIN PHARMACOL THER, V13, P563
[8] BELLET RE, 1978, CANCER TREAT REP, V62, P2095
[9] BIERMANN WA, 1979, P AM ASSOC CANC RES, V20, P373
[10] BLUM RH, 1976, P AM ASSOC CANC RES, V17, P272